130 related articles for article (PubMed ID: 18957478)
1. Ibuprofen modifies cognitive disease progression in an Alzheimer's mouse model.
Van Dam D; Coen K; De Deyn PP
J Psychopharmacol; 2010 Mar; 24(3):383-8. PubMed ID: 18957478
[TBL] [Abstract][Full Text] [Related]
2. Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model.
Van Dam D; De Deyn PP
Eur Neuropsychopharmacol; 2006 Jan; 16(1):59-69. PubMed ID: 16095884
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
4. No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease.
Hillmann A; Hahn S; Schilling S; Hoffmann T; Demuth HU; Bulic B; Schneider-Axmann T; Bayer TA; Weggen S; Wirths O
Neurobiol Aging; 2012 Apr; 33(4):833.e39-50. PubMed ID: 21943956
[TBL] [Abstract][Full Text] [Related]
5. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
6. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
[TBL] [Abstract][Full Text] [Related]
7. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
8. Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease.
Pinnen F; Sozio P; Cacciatore I; Cornacchia C; Mollica A; Iannitelli A; D'Aurizio E; Cataldi A; Zara S; Nasuti C; Di Stefano A
Arch Pharm (Weinheim); 2011 Mar; 344(3):139-48. PubMed ID: 21384412
[TBL] [Abstract][Full Text] [Related]
9. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
10. Chronic ibuprofen administration worsens cognitive outcome following traumatic brain injury in rats.
Browne KD; Iwata A; Putt ME; Smith DH
Exp Neurol; 2006 Oct; 201(2):301-7. PubMed ID: 16764859
[TBL] [Abstract][Full Text] [Related]
11. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
[TBL] [Abstract][Full Text] [Related]
12. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
[TBL] [Abstract][Full Text] [Related]
13. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
[TBL] [Abstract][Full Text] [Related]
14. Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease.
Van Dam D; Coen K; De Deyn PP
Psychopharmacology (Berl); 2008 Mar; 197(1):37-43. PubMed ID: 18008065
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer's disease.
Fu AL; Zhou CY; Chen X
Neuropharmacology; 2010; 58(4-5):722-9. PubMed ID: 20045708
[TBL] [Abstract][Full Text] [Related]
16. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
Pan X; Gong N; Zhao J; Yu Z; Gu F; Chen J; Sun X; Zhao L; Yu M; Xu Z; Dong W; Qin Y; Fei G; Zhong C; Xu TL
Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
[TBL] [Abstract][Full Text] [Related]
17. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside.
Zhang L; Xing Y; Ye CF; Ai HX; Wei HF; Li L
Behav Brain Res; 2006 Oct; 173(2):246-54. PubMed ID: 16901557
[TBL] [Abstract][Full Text] [Related]
18. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
[TBL] [Abstract][Full Text] [Related]
19. Age-related impairments in operant DMTP performance in the PS2APP mouse, a transgenic mouse model of Alzheimer's disease.
Woolley ML; Ballard TM
Behav Brain Res; 2005 Jun; 161(2):220-8. PubMed ID: 15922048
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
